International Stem Cell Co. (OTCMKTS:ISCO – Get Free Report)’s stock price crossed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $0.09 and traded as high as $0.11. International Stem Cell shares last traded at $0.11, with a volume of 1,554 shares traded.
International Stem Cell Trading Up 11.4 %
The firm has a 50 day moving average of $0.11 and a 200-day moving average of $0.09. The company has a market cap of $980,490.00, a P/E ratio of -1.53 and a beta of 0.05.
About International Stem Cell
International Stem Cell Corporation, a clinical stage biotechnology company, focuses on the development of therapeutic and biomedical products in the United States, Asia, Europe, and internationally. It develops ISC- hpNSC, a neural stem cell program that has completed the Phase I clinical trial for the treatment of Parkinson's disease, as well as for treating stroke and traumatic brain injury.
Recommended Stories
- Five stocks we like better than International Stem Cell
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- Penny Stock SurgePays Rises 70%: 1 Reason to Buy, 5 to Sell
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Top 3 Beverage Stocks Pouring Out Profits
- Dividend Payout Ratio Calculator
- CarMax and Carvana: Steering the Used Car Market
Receive News & Ratings for International Stem Cell Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for International Stem Cell and related companies with MarketBeat.com's FREE daily email newsletter.
